Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival is a research paper published in Nature Medicine (2025). On theSindex it has a DataRank of 0.659. It has been cited 80 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.659
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: CA008748
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: CA257881-01A1
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: P30 CA008748
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Grant: P50 CA257881-01A1
NCI NIH HHS
Grant: R01 CA227534
NCI NIH HHS
Grant: P50 CA257881
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 5R01CA227534-02
(PQ3) Integrative biomarkers of cancer progression and therapeutic response from germline and somatic clinical sequencing
National Institutes of Health
Grant: 3P50CA257881-04S1
Determining the mechanism of pks+ E.coli-associated carcinogenesis in early onset colorectal cancer.
Fields of Study
MeSH Terms
Keywords